Abstracts

Evaluation of a Bispecific Antibody Targeting NK Cells for the Elimination of HIV Reservoirs

Background: ‘Shock and kill’ strategies for HIV cure involve reactivating latent virus (i.e. using latency reversal agents), followed by immune-mediated clearance. HIV impairs NK function, hampering their ability to eliminate infected cells, highlighting the need for immunotherapies to enhance NK cytolytic activity against HIV. Methods: We designed a tetravalent bispecific antibody (Bi-Ab32/16), which targets the…

Impact of Gender-Affirming Hormone Therapy on HIV Reservoirs and Inflammation in Transgender Women

Background: Transgender women (TW) are at increased risk for HIV but are underrepresented in research. We investigated how the initiation of gender affirming hormone therapy (GAHT) impacts HIV reservoir (size and activity) and inflammation. Methods: TW with HIV starting estradiol-based GAHT were recruited at two clinics in San Diego, CA and Houston, TX. Participants were…

Disrupting SIV Reservoir Seeding by Targeting Stemness Pathways in Rhesus Macaques

Background: Latently HIV-infected CD4+ T cells persist indefinitely through proliferation. We previously showed that inhibition of proliferation and induction of differentiation of the long-lived, self-renewing central (CM) and stem cell memory (SCM) CD4+ T cells can be achieved in ART-treated SIV-infected rhesus macaques (RMs) through modulation of the Wnt pathway. Here, we evaluated a combined…

HIV-1 Reservoir Dynamics in Children With Early Treated, Perinatally-Acquired HIV: Does Sex Matter?

Background: Eliminating the HIV-1 reservoir is key to an effective HIV cure. Improved understanding of the size and nature of the viral reservoir will help the design of cure strategies. Here, we performed a longitudinal analysis of the total HIV reservoir in early treated, perinatally HIV-infected children. Methods: Participants were infants from the Early AntiRetroviral…

Host and Viral Factors Shape the Composition of the HIV-1 Viral Reservoir in the 2000HIV Cohort

Background: The HIV-1 host interaction exhibits remarkable diversity, resulting in various clinical profiles and virological traits, including coreceptor tropism. The 2000HIV study, which is a multi-omics study including 1895 people living with HIV-1 (PLWH) (NTC03994835), reflects this notable variability by including different clinical phenotypes, such as elite controllers (EC), viremic controllers (VC), transient controllers (TC),…

Slope of Neutralization Curve is Best Predictor of Viral Decay Response to 3BNC117 at ART Initiation

Background: Broadly neutralizing anti-HIV-1 antibodies (bNAbs) are currently being tested as component in long-acting treatment of HIV-1 and curative strategies. bNAb sensitivity of plasma viruses and thus the proviral reservoir is crucial for the clinical outcome. Currently, there is no gold standard for analyzing nor categorizing bNAb sensitivity. Methods: Plasma HIV-1 RNA from 59 eCLEAR…